Results 241 to 250 of about 4,307,548 (391)

Measures such as interstate cooperation would improve the efficacy of programs to track controlled drug prescriptions.

open access: yesHealth Affairs, 2013
R. Deyo   +6 more
semanticscholar   +1 more source

Effectiveness of Pre‐Transplant Dual GLP‐1 Receptor Agonist and SGLT2 Inhibitor Therapy on All‐Cause Mortality in Organ Transplantation Candidates with Obesity and Type 2 Diabetes: a Target‐Trial Emulation

open access: yesAdvanced Science, EarlyView.
This target trial emulation in solid organ transplant candidates with obesity and type 2 diabetes evaluates whether pre‐transplant dual therapy with GLP‐1 receptor agonists plus SGLT2 inhibitors is associated with post‐transplant mortality and kidney graft outcomes compared with monotherapy or usual care, using multinational electronic health records ...
Yu‐Nan Huang   +7 more
wiley   +1 more source

Trends in the number of LEP prescriptions according to the NDB Open Data and the drug price of NET/EE and DRSP/EE (2014–2023).

open access: green
Motoyuki Nakao (3918893)   +4 more
openalex   +1 more source

The impact of diabetes on prescription drug costs: the population-based Turin study [PDF]

open access: bronze, 2008
Graziella Bruno   +8 more
openalex   +1 more source

Cascade Therapy of Periodontitis via Sequential Release of Ribosome‐Targeting Antimicrobial Peptide and Irisin From a Multifunctional MOF‐Based System

open access: yesAdvanced Science, EarlyView.
This study presents a novel strategy for periodontitis treatment by co‐delivering a membrane‐ and ribosome‐targeting antimicrobial peptide GF and Irisin through a pH‐responsive metal‐organic framework. The system enables sequential release, providing rapid antibacterial action, anti‐inflammatory and antioxidative effects, as well as promoting bone ...
Yan Chen   +10 more
wiley   +1 more source

Association between sociodemographic status and antiepileptic drug prescriptions in children with epilepsy

open access: yesEpilepsia, 2012
P. Mattsson   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy